Log in
Enquire now
‌

US Patent 11124510 Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof

Patent 11124510 was granted and assigned to Dynavax Technologies on September, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Dynavax Technologies
Dynavax Technologies
0
Current Assignee
Dynavax Technologies
Dynavax Technologies
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
111245100
Patent Inventor Names
Melissa A. Kachura0
Radwan Kiwan0
Robert Coffman0
Stewart D. Chipman0
Date of Patent
September 21, 2021
0
Patent Application Number
202003020
Date Filed
March 2, 2020
0
Patent Citations Received
‌
US Patent 11981670 Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof
0
Patent abstract

Disclosed are alkyl chain modified 1H-imidazoquinoline compounds, derivatives and analogs thereof, as Toll-like receptor-7 and -8 agonists for enhancing immune responses. Also provided are methods of making pharmaceutical compositions containing these compounds. The present disclosure also describes methods of use for the alkyl chain modified 1H-imidazoquinoline compounds, derivatives and analogs thereof, and pharmaceutical compositions containing these compounds for the treatment of disease in a subject.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11124510 Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us